Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Prevalence and Severity of MASLD in Primary Care - a Follow-up Study

NCT07312136 is registered in ClinicalTrials.gov with Linkoeping University as lead sponsor.

NCT NCT07312136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07312136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Prevalence and Severity of MASLD in Primary Care - a Follow-up Study
Lead sponsor
Linkoeping University
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 16, 2025
Completion date
December 31, 2034
Enrollment
317 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced fibrosis, cirrhosis, hypertension, masld - metabolic dysfunction-associated steatotic liver disease, metabolic syndrome, obesity & overweight, osas (obstructive sleep apneas syndrome), sarcopenia, type 2 diabetes